Literature DB >> 7544602

The effect of systemically administered rhIGF-I/IGFBP-3 complex on cortical bone strength and structure in ovariectomized rats.

C Bagi1, M van der Meulen, R Brommage, D Rosen, A Sommer.   

Abstract

The action of systematically administered recombinant human insulinlike growth factor-I (rhIGF-I) complexed to its natural binding protein-3 (rhIGFBP-3) on cortical bone dynamic, structural, and mechanical properties was tested in previously ovariectomized (Ovx) rats. Bilateral ovariectomy or sham surgery was performed on 16-week-old female Sprague-Dawley rats. Eight weeks after surgery basal Sham and Ovx rats were killed to establish baseline cortical bone values before the initiation of treatment with rhIGF-I/IGFBP-3 complex. At that time, Ovx rats had increased body weight and body fat mass with reduced femoral BMC and BMD relative to basal Shams. Bone formation rates in Ovx rats were increased on both cortical envelopes relative to time-matched controls. The thickness of the inner lamellar bone layer and average cortical width were reduced due to increased endocortical erosion. A similar ratio between Sham and Ovx rats in body mass and composition and femoral BMC and BMD continued throughout the experiment. Sixteen weeks after surgery bone formation rates at both cortical envelopes in Ovx rats were reduced relative to Shams, but endocortical erosion remained high causing a further decrease in thickness of the inner lamellar layer. As a result of periosteal bone modeling. Ovx rats exhibited a larger femoral cross-sectional area and periosteal perimeter, as well as a thicker outer lamellar layer. Newly deposited periosteal bone increased ultimate torque values in the Ovx rats relative to Shams at 16 weeks. Treatment of Ovx rats with the rhIGF-I/IGFBP-3 complex increased body weight, lean body mass, and femoral BMC and BMD.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544602     DOI: 10.1016/8756-3282(95)00078-r

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  4 in total

1.  Short-term systemic insulin-like growth factor-1 is unable to prevent cyclosporin A-induced osteopenia in the rat.

Authors:  G N Mann; D A Sass; H K Chen; F J Buchinsky; H P Bryer; Y F Ma; W S Jee; B Rucinski; S Epstein
Journal:  Calcif Tissue Int       Date:  1996-07       Impact factor: 4.333

2.  Hypothalamic suppression decreases bone strength before and after puberty in a rat model.

Authors:  Vanessa Yingling; McKayla Elle Saine; Rupali Joshi
Journal:  Calcif Tissue Int       Date:  2009-04-07       Impact factor: 4.333

Review 3.  Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone.

Authors:  N Mauras; M W Haymond
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

4.  BMP-6 exerts its osteoinductive effect through activation of IGF-I and EGF pathways.

Authors:  W A Grasser; I Orlic; F Borovecki; K A Riccardi; P Simic; S Vukicevic; V M Paralkar
Journal:  Int Orthop       Date:  2007-07-19       Impact factor: 3.075

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.